Customize your JAMA Network experience by selecting one or more topics from the list below.
Tseng C, Yazdany J, Dudley RA, et al. Medicare Part D Plans’ Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease. JAMA Intern Med. 2017;177(4):585–588. doi:https://doi.org/10.1001/jamainternmed.2016.9386
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States,1 affecting 15.7 million adults1 and causing nearly 700 000 hospitalizations and 1.7 million emergency department visits in 2012.2 Much of the burden of COPD falls heavily on Medicare, with 1 in 9 Medicare beneficiaries diagnosed as having COPD3 and Medicare paying 51% of all US direct health care costs for COPD.4 Inhaled medications are key to relieving symptoms and improving health outcomes. However, up to 31% of Medicare beneficiaries using COPD inhalers have reported nonadherence owing to cost.5 COPD inhaler costs increased dramatically in 2008, when a ban on chlorofluorocarbon propellants phased out generic inhalers, leaving only brand-name options.6 We examined coverage and cost-sharing for COPD inhalers in Medicare Part D plans, which covered 39 million beneficiaries in 2015.
Create a personal account or sign in to: